Bariatric surgery: The indications in metabolic disease

Digestive Surgery

Volumn 31, Issue 1, 2014, Pages 6-12

  Neff, K J ^a   Le Roux, C W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bariatric surgery; Diabetes mellitus; Metabolic disease

Indexed keywords

BARIATRIC SURGERY; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; HUMAN; METABOLIC SYNDROME X; OBESITY; TREATMENT OUTCOME;

BARIATRIC SURGERY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; OBESITY; TREATMENT OUTCOME;

EID: 84900519544     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000351440     Document Type: Article

References (35)

1. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693
2. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM: Bariatric surgery and long-Term cardiovascular events. JAMA 2012; 307: 56-65
3. Chakravarty PD, McLaughlin E, Whittaker D, Byrne E, Cowan E, Xu K, Bruce DM, Ford JA: Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 2012; 10: 172-182
4. Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P, Karason K, Karlsson J, Larsson B, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Carlsson LM, Swedish Obese Subjects Study: Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653-662
5. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL: Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576
6. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F: Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585
7. Buchwald H, Oien DM: Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427-436
8. Smith BR, Schauer P, Nguyen NT: Surgical approaches to the treatment of obesity: Bariatric surgery. Med Clin North Am 2011; 95: 1009-1030
9. Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, Munoz-Navas M, Pujol-Gebelli J, Vila-Lolo C, Martinez-Gomez A, Jaun-Creix-Cornamala A: Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig 2012; 104: 72-87
10. NICE (2006): Obesity guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. http://guidance.nice.org.uk/ CG43/NiceGuidance/pdf/English (accessed March 3, 2013
11. NIH Conference: Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956-961
12. Serrot FJ, Dorman RB, Miller CJ, Slusarek B, Sampson B, Sick BT, Leslie DB, Buchwald H, Ikramuddin S: Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index 35 kg/m 2 Surgery 2011 150 684-691
13. Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention: Bariatric surgery: An IDF statement for obese type 2 diabetes. Diabet Med 2011; 28: 628-642
14. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S: Weight loss interventions in chronic kidney disease: A systematic review and meta-Analysis. Clin J Am Soc Nephrol 2009; 4: 1565-1574
15. Miras AD, Chuah LL, Lascaratos G, Faruq S, Mohite AA, Shah PR, Gill M, Jackson SN, Johnston DG, Olbers T, le Roux CW: Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care 2012; 35:e81
16. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, Strong MB, Vinik R, Wanner NA, Hopkins PN, Gress RE, Walker JM, Cloward TV, Nuttall RT, Hammoud A, Greenwood JL, Crosby RD, McKinlay R, Simper SC, Smith SC, Hunt SC: Health benefits of gastric bypass surgery after 6 years. JAMA 2012; 308: 1122-1131
17. Pournaras DJ, Aasheim ET, Sovik TT, Andrews R, Mahon D, Welbourn R, Olbers T, le Roux CW: Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012; 99: 100-103
18. MacDonald KG, Jr., Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ: The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213-220, discussion 220
19. Jimenez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J: Long-Term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 2012; 256: 1023-1029
20. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE: Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-1428
21. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M: Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008; 299: 316-323
22. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR: Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 2010; 20: 308-315
23. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR: Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 2013; 9: 7-14
24. Navaneethan SD, Yehnert H: Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 2009; 5: 662-665
25. Saliba J, Kasim NR, Tamboli RA, Isbell JM, Marks P, Feurer ID, Ikizler A, Abumrad NN: Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 2010; 147: 282-287
26. Amor A, Jimenez A, Moize V, Ibarzabal A, Flores L, Lacy AM, Vidal J: Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc 2013, E-pub ahead of print
27. Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M, Zhang S, Feng X, Gong W, Zhang Z, Zhao W, Liu C, Qu S, Hu R: Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index 35 kg/m 2 Diabetes Obes Metab 2012; 14: 262-270
28. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ: The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: A systematic review and economic evaluation. Health Technol Assess 2009; 13: 1-190, 215-357
29. Huang CK, Shabbir A, Lo CH, Tai CM, Chen YS, Houng JY: Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg 2011; 21: 1344-1349
30. Shah SS, Todkar JS, Shah PS, Cummings DE: Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index index 35 kg/m 2 . Surg Obes Relat Dis 2010; 6: 332-338
31. DePaula AL, Macedo AL, Mota BR, Schraibman V: Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 2009; 23: 1313-1320
32. Shimizu H, Timratana P, Schauer PR, Rogula T: Review of metabolic surgery for type 2 diabetes in patients with a BMI 35 kg/m 2 . J Obes 2012; 2012: 147256
33. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D'Alessandro G, Andraghetti G, Cordera R: Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 2011; 253: 699-703
34. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: A systematic review and metaanalysis. JAMA 2004; 292: 1724-1737
35. Sjoholm K, Anveden A, Peltonen M, Jacobson P, Romeo S, Svensson PA, Sjöström L, Carlsson LM: Evaluation of current eligibility criteria for bariatric surgery: Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study. Diabetes Care 2013, Epub ahead of print